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Edited by Shou-Wei DingAbstract In mammalian cells, RNA interference can be medi-
ated by synthetic duplex RNAs, termed small interfering RNAs
(siRNAs), which assist in cleaving completely complementary
mRNA transcripts. MicroRNAs (miRNAs) are endogenous
small RNAs that assist in translationally repressing mRNAs
with regions of partial complementarity, but may also reduce
transcript levels. Since miRNAs predominantly interact with
the 3 0 UTRs of transcripts, we sought to ask if mismatched siR-
NAs mimicking miRNAs aﬀect cognate mRNA levels as a func-
tion of target site location. We ﬁnd that mismatched siRNAs
targeting the 3 0 UTRs of two endogenous transcripts yield a
greater reduction in mRNA levels than those targeting the coding
region. Our ﬁndings demonstrate the importance of target site
location within endogenous mRNAs for small RNAs associated
with RNAi.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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RNA interference (RNAi) is a gene silencing mechanism
triggered by a variety of double stranded RNAs. In mamma-
lian cells, RNAi can be mediated by short (21 nucleotide,
nt) duplex RNAs termed small interfering RNAs (siRNAs),
which are typically introduced via the direct transfection of
synthetic siRNAs or are derived from the intracellular process-
ing of expressed short hairpin RNA precursors (shRNAs). In
the cytoplasm, siRNA duplexes are loaded into the RNA-in-
duced silencing complex (RISC) where a single strand is pref-
erentially retained and acts to guide the complex to target
messages with perfect complementarity (reviewed [1]). Once
engaged, RISC mediates cleavage of target transcripts between
nucleotides pairing to bases 10 and 11 of the siRNA, as mea-
sured from its 5 0 end [2,3].
In mammalian cells, siRNAs take advantage of at least
part of the endogenous machinery used by microRNAs (miR-
NAs). miRNAs are 22 nt RNAs derived from longer hair-
pin-containing transcripts that undergo both nuclear
(Drosha-mediated) and cytoplasmic (Dicer-mediated) pro-
cessing and have been found to play a role in regulating
the expression of genes involved in a wide variety of cellular
processes (reviewed [4]). miRNAs enter a complex similar, if*Corresponding author. Fax: +1 301 594 0345.
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doi:10.1016/j.febslet.2006.05.056not identical, to that of siRNAs. Binding of this microribonu-
cleoprotein (miRNP) complex to target mRNAs can lead to
transcript cleavage or translational repression. Initial studies,
predominantly performed using reporter constructs, sug-
gested that complete complementarity between miRNAs
and target mRNAs results in cleavage, whereas mismatches
between them result in translational repression. For example,
miRNAs capable of translational repression have the ability
to cleave targets with 3 0 UTRs engineered to contain com-
pletely complementary sequences [5,6]. Conversely, functional
siRNAs repress translation of reporter genes containing mul-
tiple imperfect binding sites in their 3 0 UTRs [5,7]. However,
more recent studies have shown that miRNAs with less than
complete complementarity can induce reductions in cognate
transcript levels [8–11]. Furthermore, miRNAs have been
shown to colocalize with their target transcripts in sites of
mRNA degradation known as cytoplasmic processing bodies
or P-bodies where degradation through a process of cap re-
moval followed by 5 0 to 3 0 exonuclease activity may occur
[12–16].
In animals, miRNAs are primarily thought to interact with
the 3 0 UTR of target mRNAs [17]. For example, lin-4, the
ﬁrst identiﬁed miRNA, was found to regulate lin-14 protein
expression in Caenorhabditis elegans through interactions
with multiple sites of partial complementary within the lin-
14 3 0 UTR [18,19]. In mammalian systems, most data also
suggests an association between miRNA activity and se-
quences within the 3 0 UTR of target mRNAs. For example,
the delivery of a series of known human miRNAs into cell
lines normally devoid of these miRNAs results in the down-
regulation of targets with corresponding complementarity in
their 3 0 UTRs [9]. Given the ability of miRNAs to induce a
modest degree of reduction in target transcript levels and
the predominance of their interactions with target 3 0 UTRs,
we sought to investigate whether mismatched siRNAs, de-
signed to mimic miRNAs, would exhibit activity as a func-
tion of target site location within endogenous mRNAs. We
have found that mismatched siRNAs targeting 3 0 UTRs exhi-
bit a greater ability to reduce cognate mRNA levels as com-
pared to those targeting within the coding region of the same
transcripts. Since in many cases miRNAs appear to induce a
greater eﬀect on translation than would be predicted from
observed reductions in target mRNA levels, we examined
the downstream eﬀects of these mismatched siRNAs on cor-
responding protein levels. We found that mismatched siR-
NAs appear to reduce protein levels in a manner consistent
with their eﬀects on mRNA levels with those targeting the
3 0 UTR exhibiting greater activity.blished by Elsevier B.V. All rights reserved.
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2.1. Cell culture and reagents
All cell culture reagents were obtained from Invitrogen (Carlsbad,
CA). NCI/ADR-RES cells were a gift of the laboratory of Michael
M. Gottesman (LCB, CCR, NCI) and maintained in DMEM contain-
ing 10% fetal bovine serum (FBS). HCT-116 colon cancer cells were
obtained from the NCI Developmental Therapeutics Program and
maintained in RPMI containing 5% FBS. Both were passaged every
4–5 days. The siRNAs used in this study were obtained from Qiagen
Inc. (Germantown, MD) (see Figs. 1 and 3 for sequences). All siRNAs
were synthesized with a two base 3 0 deoxynucleotide overhang. The
negative siRNA duplex consisted of 5 0-r(ACGUGACACGUUCG-
GAGAA)dTdT and 5 0-r(UUCUCCGAACGUGUCACGU)dTdT
strands.
2.2. Transfections for RNA analysis
For analysis of mRNA, all transfections were performed in 96 well
plates and in triplicate. For transfection ofNCI/ADR-RES cells, siRNA
(10 pmol) was added to individual plate wells in 25 lL of serum free
DMEM. siLentFect lipid reagent (Bio-Rad Laboratories, Hercules,
CA) was subsequently added to siRNA containing wells in 25 lL of ser-
um free DMEM to provide a ﬁnal lipid:siRNA ratio of 2:1 (w/w). The
resulting mixture was allowed to complex for 30 min at rt. NCI/ADR-
RES cells (10000) were then added in 50 lL of DMEM containing
20% FBS to yield transfection mixtures consisting of 100 nM siRNA
in DMEM containing 10% FBS. Transfection of HCT-116 cells were
performed analogously except that the ﬁnal transfection mixtures con-
sisted of 50 nM siRNA in RPMI containing 5% FBS, while still using
a lipid:siRNAratio of 2:1 (w/w). Final transfectionmixtures for both cell
lines were incubated at rt for 45 min before being placed at 37 C in a
humidiﬁed atmosphere containing 5% CO2. MDR1 (ABCB1) and
CTNNB1 (b-catenin) mRNA levels were analyzed 20 h post-transfec-
tion by using the QuantiGene Reagent System (Panomics, Fremont,
CA). Brieﬂy, the QuantiGene Reagent System is a nucleic acid hybrid-
ization assay that utilizes branched DNA technology to amplify and
measure signal from mRNA obtained directly from crude cell lysates.
MDR1 and CTNNB1 mRNA levels were normalized to cyclophilin B
(PPIB)mRNA.Reported changes in bothMDR1 andCTNNB1mRNA
levels are representative of at least two independent experiments.
2.3. b-Catenin protein analysis
The eﬀects of respective siRNAs on b-catenin protein levels were
analyzed by Western blot 72 h post transfection. Transfections were
performed as described above for RNA analysis except that they5'-
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Fig. 1. Completely complementary siRNAs and their mismatch-containing
CTNNB1.were conducted in 6 well plates and scaled 30 fold. siRNAs against
b-catenin were evaluated at a ﬁnal concentration of 100 nM in NCI/
ADR-RES cells and 50 nM in HCT-116 cells. Cells were washed twice
with ice cold PBS (1 mL) before treatment with lysis buﬀer (20 mMTris
(pH 8.0), 140 mMNaCl, 1 mMMgCl2, 1 mMCaCl2, 1% Triton X, 10%
glycerol, 1 mMPMSF, 200 lL · 15 min at 4 C). Lysates were vortexed
and centrifuged at 14000 rpm for 10 min to remove insoluble cell
debris. The Micro BSA Protein Assay (Pierce, Rockland, IL) was used
to determine total protein concentration and 10 lg of total protein was
chromatographed by SDS/PAGE (4–15% gradient, BioRad Laborato-
ries) followed by semi-dry transfer to nitrocellulose membranes. Mem-
branes were blocked for 1 h using 5% blotting grade non-fat dried milk
in TBST (Tris buﬀered saline (pH 7.4), 0.1% Tween 20) and incubated
with mouse anti-b-catenin IgG (1:2000, TBST, 1% milk) overnight at
4 C . Blots were washed with TBST (6 · 5 min) and incubated with
Alexa Fluor 680 conjugated goat anti-mouse IgG (1:4000, TBST, 1%
milk) for 2 h at rt. Blots were washed with TBST (6 · 5 min) and
imaged on a Li-Cor Odyssey Imager (Li-Cor, NE). Reported results
are representative of three independent experiments.
2.4. MDR1 protein analysis
NCI/ADR-RES cells were transfected as described for RNA analy-
sis except that they were performed in 6 well plates and scaled 30 fold.
MDR1-directed siRNAs were used at a ﬁnal concentration of 100 nM.
Eﬀects on MDR1 protein levels were measured 48 h post-transfection
by analyzing the abundance of surface protein on living cell by using
MRK16 antibody similarly to methods previously described [20].
The reported reduction in MDR1 reﬂects the average and standard
deviation of duplicate experiments, as measured by comparing the
background corrected mean ﬂuorescence of MDR1-directed siRNA
and negative control siRNA transfected cells.3. Results
3.1. CTNNB1-directed siRNAs diﬀerentially aﬀect target
mRNA and protein levels
In order to determine if mismatched siRNAs exhibit activ-
ity as a function of target site location, we designed a series
of mismatched siRNAs targeting either the coding region or
3 0 UTR of endogenously expressed transcripts. These siRNAs
were constructed to form a mismatched bulge between the
siRNA and target mRNA over the putative RISC cleavage-3'
3' UTR
36972556
_001904)
CTNNB1-2si
(3504-3524)mRNA
siRNA (antisense)
A
U
A
U
U
A
G
C
G
C
G
C
A
U
U
A
G
C
G
C
A
U
A
U
U
A
G
C
A
U
C
G
U
A
A
U
G
C
U
A
A
T
5'-
3'-
CTNNB1-2mi
mRNA
siRNA (antisense)
A
U
A
U
U
A
G
C
A
U
C
G
U
A
A
U
U
A
G
C
G
C
G
C
A
U
U
A
G
C
G
C
G
C
U
A
5'-
3'-
AA
CCC
CTNNB1-2Bmi
mRNA
siRNA (antisense)
A
U
A
U
U
A
G
C
A
U
C
G
U
A
A
U
U
A
G
C
G
C
G
C
A
U
U
A
G
C
G
C
G
C
U
A
5'-
3'-
AA
AGG
analogues designed to target either the coding region or 3 0 UTR of
3696 S.E. Martin, N.J. Caplen / FEBS Letters 580 (2006) 3694–3698site and conformed to the consensus sequence for predicted
human miRNAs [17]. Such miRNA mimics are reportedly
cleavage incompetent, but can act in a manner analogous
to endogenous miRNAs and result in a corresponding reduc-
tion in target protein levels [7]. We initially designed two
miRNA analogues (CTNNB1-1mi and CTNNB1-2mi)
against either the coding region or 3 0 UTR of CTNNB1
(Fig. 1). Completely complementary siRNAs (CTNNB1-1si
and CTNNB1-2si) served to help validate the viability of
respective target sites.
As an initial experiment, HCT-116 colon cancer cells were
transfected with varying concentrations of each siRNA rang-
ing from 1 to 50 nM. To ensure comparable transfection con-
ditions at each concentration, total siRNA was held constant
at 50 nM by supplementing with negative control siRNA while
maintaining a lipid:siRNA ratio of 2:1 (w/w). As expected, the
completely complementary siRNAs CTNNB1-1si and
CTNNB1-2si induced a signiﬁcant reduction in CTNNB1 lev-
els 20 h post-transfection (Fig. 2). Not surprisingly, the mis-
match-containing siRNA CTNNB1-1mi exhibited no
activity. However, CTNNB1-2mi appeared to signiﬁcantly re-
duce CTNNB1 levels. Moreover, the activity of CTNNB1-2mi
remained approximately constant at concentrations as low as
10 nM, similar to the activity proﬁle exhibited by completely
complementary siRNAs. To examine if the activity ofPe
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Fig. 2. The eﬀect of siRNAs on both CTNNB1 mRNA and b-catenin prot
siRNAs. Levels are reported as the percent of CTNNB1 mRNA found in cells
conducted in NCI/ADR-RES cells. (C) Western blot of HCT-116 cells tr
performed to verify that the observed signals fell within an approximately liCTNNB1-2mi was somehow a function of its guide strand se-
quence, an analogous siRNA, CTNNB1-2Bmi, was designed
diﬀering only in the base composition of the putative bulge se-
quence (Fig. 1). CTNNB1-2Bmi exhibited similar activity to
that of CTNNB1-2mi suggesting that bulge composition is
not the determining factor for the observed eﬀect (Fig. 2).
In order to determine if the above observations were repro-
ducible in a diﬀerent system, we extended these studies into
NCI/ADR-RES cells (a drug resistant cell line thought to be
of ovarian origin [21]). Optimization of transfection conditions
using the activity of CTNNB1-1si and CTNNB1-2si as a mea-
sure of transfection eﬃciency indicated that NCI/ADR-RES
cells required twice as much lipid to achieve comparable activ-
ity as that observed in HCT-116. Thus for these experiments,
the total siRNA concentration was held constant at 100 nM,
again supplemented with negative siRNA, with a lipid:siRNA
ratio of 2:1 (w/w). Almost identical activity proﬁles were ob-
served in NCI/ADR-RES cells as were observed in HCT-
116, with CTNNB1-1mi exhibiting no activity and
CTNNB1-2mi and 2Bmi exhibiting similar proﬁles as found
with the completely complementary siRNAs (Fig. 2).
We next examined the eﬀects of these siRNAs on b-catenin
protein levels in HCT-116 cells by Western blot. Changes in b-
catenin protein levels were assessed by comparing those found
in CTNNB1-siRNA treated cells versus cells transfected with1
CTNNB1-1si
CTNNB1-2mi
CTNNB1-1mi
CTNNB1-2Bmi
CTNNB1-2si
CTNNB1-1si
CTNNB1-2mi
CTNNB1-1mi
CTNNB1-2Bmi
CTNNB1-2si
1
CDS
3' UTR
CDS
3' UTR
ein levels. (A) CTNNB1 mRNA levels in HCT-116 cells treated with
transfected with negative control siRNA. (B) The same as in A. except
eated with the indicated siRNA. A serial dilution of cell lysate was
near range.
S.E. Martin, N.J. Caplen / FEBS Letters 580 (2006) 3694–3698 3697negative control siRNA. As shown in Fig. 2, the completely
complementary siRNAs CTNNB1-1si and -2si, as well as the
3 0 UTR targeting mismatched siRNA CTNNB1-2mi yielded
appreciable reductions in b-catenin protein levels (Fig. 2). As
with the eﬀects observed with CTNNB1 mRNA, the mis-
matched miRNA analogue targeting the coding region of
CTNNB1 (CTNNB1-1mi) exhibited no activity. Similar results
were obtained using NCI/ADR-RES cells (data not shown).
3.2. MDR1-directed siRNAs exhibit a similar trend with regard
to MDR1 mRNA and protein levels
The results obtained with siRNAs directed against CTNNB1
suggest that mismatched siRNAs may exhibit diﬀerential activ-
ities as a function of target site location. To further examine
this possibility, we synthesized a similar series of siRNAs di-
rected against MDR1. For these experiments, we designed
three completely complementary siRNAs (MDR1-1si,
MDR1-2si, and MDR1-3si) and their corresponding bulged
mismatched miRNA analogues (Fig. 3). MDR1-1si and
MDR1-2si were designed to target the coding region, whereas
MDR1-3si was designed to target the 3 0 UTR. As shown in0
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Fig. 3. Experiments conducted against MDR1 in NCI/ADR-RES cells. (A
analogues designed to target either the coding region or 3 0 UTR of MDR1. (
Levels are reported as the percent of MDR1 mRNA found in cells transfecte
protein levels as compared to levels found in cells transfected with negativeFig. 3, MDR1-directed siRNAs tested in NCI/ADR-RES cells
showed analogous activity as that observed with CTNNB1-di-
rected siRNAs. All completely complementary siRNAs re-
sulted in an appreciable reduction in MDR1 transcript levels.
Bulge-containing mismatch siRNAs targeting the coding re-
gion (MDR1-1mi and MDR1-2mi) exhibited no measurable
activity. However, as in the case of CTNNB1-2mi, the miRNA
analogue targeting the 3 0 UTR (MDR1-3mi) resulted in de-
creased MDR1 levels. As with CTNNB1, we sought to exam-
ine the eﬀects of these siRNAs on MDR1 protein levels. We
found that completely complementary siRNAs as well as
MDR1-3mi resulted in a measured decrease in MDR1 protein
whereas the mismatched siRNAs targeting the coding region
(MDR1-1mi and MDR1-2mi) were clearly less active (Fig. 3).4. Discussion
We have demonstrated that mismatched siRNAs appear to
exhibit activity as a function of target site location, with those
targeting the 3 0 UTR inducing a greater reduction in targeti
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3698 S.E. Martin, N.J. Caplen / FEBS Letters 580 (2006) 3694–3698mRNA levels than those targeting the coding region within the
same transcripts. This activity does not appear to arise from
diﬀerences in target site accessibility, since the activity of com-
pletely complementary siRNAs does not seem to follow the
same trend. For example, one of the completely complemen-
tary siRNAs targeting the coding region of MDR1, MDR1-
2si, exhibits greater activity than that of the completely
complementary 3 0 UTR targeting siRNA MDR1-3si. These
results are in strong agreement with a recent report describing
a statistical correlation between the oﬀ-target eﬀects induced
by a series of siRNAs and complementarity within the 3 0
UTRs of oﬀ-target transcripts [22]. Presumably, the activity
of 3 0 UTR targeting siRNAs may relate to a miRNA type
pathway. Since miRNAs are thought to exhibit a greater eﬀect
on translation than would be predicted from changes in target
mRNA levels, we examined the eﬀects of mismatched siRNAs
on corresponding protein levels to determine if those targeting
the coding region aﬀected translation beyond their eﬀects on
target transcript levels. We found that these mismatched
siRNAs seem to aﬀect protein levels in a manner consistent
with changes in mRNA levels, with those targeting the 3 0
UTR exhibiting greater activity than the coding region ana-
logues. However, it is important to note that other reported
mismatched siRNAs targeting the coding region of endoge-
nous targets have the ability to repress translation [23]. This
study demonstrates a relative diﬀerence between the activities
of comparably designed mismatched siRNAs (miRNA mim-
ics) targeting either the coding region or 3 0 UTR within the
same transcript. These ﬁndings may oﬀer functional support
for the preponderance of endogenous miRNA target sites in
3 0 UTRs and further illuminates the diﬀerent functional eﬀects
of small RNAs entering the RNAi pathway.
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